NCT07558590

Brief Summary

This study takes place in the framework of the PostMarket Clinical Follow-up plan of the Shoulder Systems commercialized by FX SHOULDER SOLUTIONS. The included cases will be followed for 10 years after index surgery. Primary objective is the assessment in real life of the revision rate of the shoulder systems at long-term. Secondary objectives are

  • Revision rate at each post op visit
  • Range of motion at each post op visit
  • Quick Dash, Constant, American Shoulder and Elbow Surgeons Shoulder Score (ASES), Subjective Shoulder Value (SSV), Pain scores at each post op visit
  • Radiological assessment of implant positioning through geometrical parameters at each post op visit
  • Incidence of complications at each post op visit
  • Qualitative feedback from surgeons on the instrumentation

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,004

participants targeted

Target at P75+ for all trials

Timeline
135mo left

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
2 countries

22 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jun 2020Jun 2037

Study Start

First participant enrolled

June 1, 2020

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

April 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 30, 2026

Completed
10.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2036

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2037

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

16.6 years

First QC Date

April 24, 2026

Last Update Submit

April 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Revision rate (KM) at 10 years postoperative

    at the end of the postoperative follow-up period of 10 years

Secondary Outcomes (10)

  • Revision rate (KM) at each post-operative visits

    At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years)

  • Range of Motions at each postoperative visit

    At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)

  • QuickDASH score at each follow-up visit

    At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)

  • Constant-Murley score at each follow-up visit

    At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)

  • ASES score at each postoperative visit

    At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)

  • +5 more secondary outcomes

Study Arms (11)

Group 1: HUMELOCK II® TSA

Subjects treated with HUMELOCK II® Anatomic Shoulder System

Procedure: Shoulder arthroplasty

Group 21: cementless HUMELOCK II® RSA - trauma

Subjects treated with cementless HUMELOCK II® Reversible Shoulder System for traumatic indications

Procedure: Shoulder arthroplasty

Group 22: cemented long HUMELOCK II® RSA - revision

Subjects treated with cemented long HUMELOCK II® Reversible Shoulder System for revision indications

Procedure: Shoulder arthroplasty

Group 31: SHUMELOCK REVERSED® - degenerative

Subjects treated with HUMELOCK REVERSED® Shoulder System for degenerative indications

Procedure: Shoulder arthroplasty

Group 32: HUMELOCK REVERSED® - trauma

Subjects treated with HUMELOCK REVERSED® Shoulder System for traumatic indications

Procedure: Shoulder arthroplasty

Group 4: cementless HUMERIS® Anatomic - degenerative

Subjects treated with cementless HUMERIS® Anatomic Shoulder System for degenerative indications

Procedure: Shoulder arthroplasty

Group 5: cementless HUMERIS® RSA - degenerative

Subjects treated with cementless HUMERIS® Reversible Shoulder System for degenerative indications

Procedure: Shoulder arthroplasty

Group 6: EASYTECH® TSA - degenerative

Subjects treated with EASYTECH® Anatomic Shoulder System for degenerative indications

Procedure: Shoulder arthroplasty

Group 7: EASYTECH® RSA - revision

Subjects treated with EASYTECH® Reversible Shoulder System for revision indications

Procedure: Shoulder arthroplasty

Group 8: EASYTECH® RSA - degenerative

Subjects treated with EASYTECH® Reversed Shoulder System for degenerative indications

Procedure: Shoulder arthroplasty

Group 33: HUMELOCK REVERSED® - revision

Subjects treated with HUMELOCK REVERSED® Shoulder System for revision indications

Procedure: Shoulder arthroplasty

Interventions

Total anatomical (TSA), hemi anatomical (HSA) or reversed (RSA) shoulder arthroplasties.

Group 1: HUMELOCK II® TSAGroup 21: cementless HUMELOCK II® RSA - traumaGroup 22: cemented long HUMELOCK II® RSA - revisionGroup 31: SHUMELOCK REVERSED® - degenerativeGroup 32: HUMELOCK REVERSED® - traumaGroup 33: HUMELOCK REVERSED® - revisionGroup 4: cementless HUMERIS® Anatomic - degenerativeGroup 5: cementless HUMERIS® RSA - degenerativeGroup 6: EASYTECH® TSA - degenerativeGroup 7: EASYTECH® RSA - revisionGroup 8: EASYTECH® RSA - degenerative

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population is issued from investigators' patient population.

You may qualify if:

  • Indication for hemi or total shoulder replacement with one of the FX SHOULDER SOLUTIONS Shoulder Systems, according to its IFU and surgical technique.
  • Patient aged 18 years and above
  • Patient insured with a social security system
  • Has been informed and did consent to participate to the study.

You may not qualify if:

  • Neurological pathologies compromising the shoulder stability
  • Morbid obesity
  • Muscular deficiencies impairing the shoulder joint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

CHU Amiens Picardie

Amiens, 80054, France

RECRUITING

CHU d' Angers

Angers, 49933, France

RECRUITING

Hôpital Jean Minjoz

Besançon, 25030, France

RECRUITING

Clinique Aguiléra

Biarritz, 64200, France

RECRUITING

Hôpital privé Saint-Martin

Caen, 14000, France

RECRUITING

Infirmerie Protestante

Caluire-et-Cuire, 69300, France

RECRUITING

CHMS Chambéry

Chambéry, 73011, France

RECRUITING

HÔPITAUX CIVILS de Colmar

Colmar, 68024, France

RECRUITING

Hôpital privé Dijon Bourgogne

Dijon, 21000, France

RECRUITING

Clinique Saint Charles

La Roche-sur-Yon, 85016, France

RECRUITING

Clinique chirurgicale Porte Océane

Les Sables-d'Olonne, 85101, France

RECRUITING

Clinique Saint Charles

Lyon, 69001, France

RECRUITING

L'hôpital privé du confluent

Nantes, 44277, France

RECRUITING

Hopital Bichat

Paris, 75018, France

RECRUITING

Clinique des Maussins

Paris, 75020, France

RECRUITING

Pavillon de la Mutualite

Pessac, 33608, France

RECRUITING

Clinique Saint Michel et Sainte Anne

Quimper, 29000, France

RECRUITING

Clinique Mutualiste

Saint-Etienne, 42000, France

RECRUITING

Polyclinique de l'Atlantique

Saint-Herblain, 44819, France

RECRUITING

C. H. St- Nazaire

Saint-Nazaire, 44606, France

RECRUITING

Clinique de l'Orangerie

Strasbourg, 67000, France

RECRUITING

Centre Hospitalier Princesse Grace

Monaco, 98000, Monaco

RECRUITING

MeSH Terms

Conditions

Shoulder FracturesRotator Cuff InjuriesArthritis

Interventions

Arthroplasty, Replacement, Shoulder

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesShoulder InjuriesRuptureTendon InjuriesJoint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2026

First Posted

April 30, 2026

Study Start

June 1, 2020

Primary Completion (Estimated)

December 31, 2036

Study Completion (Estimated)

June 1, 2037

Last Updated

April 30, 2026

Record last verified: 2026-04

Locations